23442834Marcellin P, Craxi A, Brandao-Mello CE, Di Bisceglie AM, Andreone P, Freilich B, Rajender Reddy K, Olveira Mart?n A, Teuber G, Messinger D, Hooper G, Wat C, Tatsch F, Jensen DMJournal of clinical gastroenterologyAntiviral Agents; Hepatitis C, Chronic; Interferon-alpha; Polyethylene Glycols; RibavirinAdult; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Male; Middle Aged; Predictive Value of Tests; Randomized Controlled Trials as Topic; Recombinant Proteins; Retreatment; Time Factors; Treatment OutcomePredicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatment. J Clin Gastroenterol. 2013 Oct; 47(9):786-93.J Clin Gastroenterol2013-10-01T00:00:002013Predicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatment.Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD016898Chemicals & Drugs27660.954042Interferon-alphaD016896Concepts & Ideas36434750.519249Treatment OutcomeD011092Chemicals & Drugs22550.94896Polyethylene GlycolsD000998Chemicals & Drugs361320.879961Antiviral AgentsD011994Chemicals & Drugs762510.939534Recombinant ProteinsD011237Concepts & Ideas2035210.870715Predictive Value of TestsD016032Concepts & IdeasProcedures1233390.861492Randomized Controlled Trials as Topic4ProfessorD019233Procedures7110.993317RetreatmentD008875Concepts & IdeasLiving Beings48498180.3737Middle AgedD019698Disorders12780.899313Hepatitis C, ChronicD000328Living Beings51785940.393502AdultD008297Physiology565156330.299056MaleD012254Chemicals & Drugs5320.970274RibavirinD005260Physiology580162050.293542FemaleD013997Concepts & Ideas34316150.70981Time FactorsRush University, Rush Medical Collegetrue1ProfessorProfessorInternal Medicine, Division of Digestive Diseases and NutritionDonaldJensenDonald M. Jensen349747Jensen, DonaldProfessorAuthorship 21305140.4832550.4832551authors10.2517has subject areaD006801Living Beings644293510.211905HumansD004359Procedures902410.940349Drug Therapy, Combination